Catalyst News and Research

RSS
DT-109 shows promise in treating atherosclerosis and liver disease

DT-109 shows promise in treating atherosclerosis and liver disease

Anxiety and depression in children increased steadily from 2016 to 2022

Anxiety and depression in children increased steadily from 2016 to 2022

New antibiotic compound emerges as strong candidate in the fight against MRSA

New antibiotic compound emerges as strong candidate in the fight against MRSA

Mirvie reveals new advances in the biological understanding of hypertensive disorders of pregnancy

Mirvie reveals new advances in the biological understanding of hypertensive disorders of pregnancy

The thalamus could be a strategic target for treating cognitive dysfunction

The thalamus could be a strategic target for treating cognitive dysfunction

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ethical hurdles of integrating telemedicine in sexual medicine

Ethical hurdles of integrating telemedicine in sexual medicine

Mapping the brain network behind generalized epilepsy

Mapping the brain network behind generalized epilepsy

New light-driven process could accelerate the discovery of new drugs

New light-driven process could accelerate the discovery of new drugs

IL-12 targeting could open pathways for new Alzheimer's treatments

IL-12 targeting could open pathways for new Alzheimer's treatments

Neuropeptide Y identified as key driver of pancreatic cancer spread

Neuropeptide Y identified as key driver of pancreatic cancer spread

IRENE network enhances stroke care and patient outcomes in Europe

IRENE network enhances stroke care and patient outcomes in Europe

Targeted psychological interventions can enhance long-term resistance to misinformation

Targeted psychological interventions can enhance long-term resistance to misinformation

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Breakthrough method opens door to fluorinated oxetane drug molecules

Breakthrough method opens door to fluorinated oxetane drug molecules

Key research priorities for understanding and treating appendiceal cancer

Key research priorities for understanding and treating appendiceal cancer

Simple text-messaging system saves time for cancer patients during treatment visits

Simple text-messaging system saves time for cancer patients during treatment visits

Three new drug regimens offer hope for drug-resistant tuberculosis

Three new drug regimens offer hope for drug-resistant tuberculosis

Innovative approach tracks SARS-CoV-2 in the blood to guide COVID-19 treatment

Innovative approach tracks SARS-CoV-2 in the blood to guide COVID-19 treatment

New technique identifies SARS-CoV-2 in blood and other fluids with high sensitivity

New technique identifies SARS-CoV-2 in blood and other fluids with high sensitivity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.